The global programmable infusion pumps and catheters market by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 8,365.3 million in 2017, and is projected to exhibit a CAGR of 5.8% over the forecast period (2018–2026), as highlighted in a new report.
New product launches and therapeutic advantages, such as dose monitoring, offered by programmable infusion pumps over manual counterparts are expected to boost the global programmable infusion pumps and catheters market growth. Moreover, key players in the market are focused on launching new products in order to enhance their market share. For instance, in 2018, Baxter International Inc., a company involved in innovative technology for medication delivery, received approval for Spectrum IQ Infusion System with Dose IQ Safety Software from U.S. Food and Drug Administration (FDA). Spectrum IQ system is designed specifically for bi-directional electronic medical records (EMR) integration, along with features that assist appropriate dosing of medications to the patient.
Browse 24 Market Data Tables and 33 Figures spread through 181 Pages and in-depth TOC on global programmable infusion pumps and catheters market, by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026 To know the latest trends and insights prevalent in the global programmable infusion pumps and catheters market, click the link below:
Strategic mergers and acquisitions by key players is expected to support the global programmable infusion pumps and catheters market growth. For instance, in April 2017, BD (Becton, Dickinson and Company), a global medical technology company completed the acquisition of Caesarea Medical Electronics (CME), a global manufacturer of infusion pump systems. This merger resulted in expansion of company’s home care, specialty applications, and ambulatory infusion portfolio.
Key Takeaways of the global programmable infusion pumps and catheters market:
- The global programmable infusion pumps and catheters market is expected to exhibit a CAGR of 8% over the forecast period. This is owing to increasing research and development activities by key players and product launches.
- Manufacturers are focused on strategic mergers and acquisitions, as well as raising funds for obtaining product clearance and product commercialization
- North America is expected to be dominant in the global programmable infusion pumps and catheters market over the forecast period, owing to product launches and active research and development activities by key players in the region
- Major players operating in the global programmable infusion pumps and catheters market include, ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic plc., Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.
